PatientsLikeMe appoints R&D head
This article was originally published in Scrip
Executive Summary
PatientsLikeMe, a patient network and a real-time research platform service, has appointed Dr Jason Johnson executive vice-president and head of R&D. Dr Johnson will lead the company's research, data science, and informatics teams, which focus on analyzing and merging patient-reported and other data types to develop models of disease progression and generate new insights about disease, treatments, and health. He will report directly to CEO Martin Coulter. A computational biologist and information science strategist, Dr Johnson comes to PatientsLikeMe from Merck, where most recently he was associate vice-president for scientific informatics.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.